Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial-Reference-Cited by-同舟云学术

Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial

Published:2013-11-05 Issue:4 Volume:24 Page:561-566
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Kurasawa Takahiko¹²,Nagasawa Hayato¹,Kishimoto Mayumi³,Amano Koichi¹,Takeuchi Tsutomu²,Kameda Hideto²⁴

Affiliation:

1. Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan

2. Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

3. Santen Pharmaceutical Co., Ltd. Kita-ku, Osaka, Japan

4. Division of Rheumatology, Department of Internal Medicine, School of Medicine, Toho University, Meguro-ku, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/14397595.2013.844886

Reference24 articles.

1. Developments in the scientific understanding of rheumatoid arthritis

2. Treating rheumatoid arthritis to target: recommendations of an international task force

3. Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals

4. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

5. Comparison of Treatment Strategies in Early Rheumatoid Arthritis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review;Arthritis Research & Therapy;2023-11-20

2. Therapeutic applications of low-molecular-weight thiols and selenocompounds;Redox Chemistry and Biology of Thiols;2022

3. Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission;Scientific Reports;2021-03-25

4. The long-term observation of patients with rheumatoid arthritis who achieved a biological disease-modifying antirheumatic drug-free condition with adalimumab;Modern Rheumatology;2020-10-12

5. Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center;Internal Medicine;2020-08-15